Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Synthomer Share News (SYNT)
SYNT Share
Price
SYNT Share
News
SYNT Share
Chat
SYNT Share
Trades391
SYNT
Live RNS
SYNT Share
Charts
SYNT Level 2
Console
SYNT Live
Share Price
SYNT Broker
Ratings
SYNT Directors
Deals
SYNT Financial
Diary
SYNT
Fundamentals
SYNT Short
Positions1
SYNT
Media
SYNT Company
Research
SYNT Company
Timeline1
Share Price Information for Synthomer (SYNT)
Last checked at -
Last checked at 
Intraday Synthomer Share Chart
Synthomer News
Synthomer agrees sale of Czech acrylate monomers business
(Sharecast News) - Synthomer announced on Friday that it has agreed to sell its Czech acrylate monomers business to Mutares, as the chemicals group co...
IN BRIEF: Synthomer to divest "capital-intensive" Acrylate Monomers
Synthomer PLC - London-based developer of polymer chemicals - Agrees to divest the operating company of its Czech Republic-based Acrylate Monomers bus...
WINNERS & LOSERS: S4 Capital hit by "client caution"; NAHL in profit
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.
Berenberg hikes target price on Synthomer
(Sharecast News) - Analysts at Berenberg hiked their target price on chemicals business Synthomer from 60p to 100p on Wednesday as it said the firm ha...
LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi
(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:
WINNERS & LOSERS: Shield Therapeutics down on Medicaid concerns
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.
EARNINGS AND TRADING: IG Design sees full-year sales above forecast
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...
Follow the stocks
